Endogenous Endophthalmitis in the Inpatient Setting
NCT01323868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145
Last updated 2014-11-18
Summary
The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.
Conditions
- Endophthalmitis
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Theodore Leng · Stanford University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- United States
Study Locations
More Related Trials
-
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
NCT04030962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ocular Surface Microbiome in Dry Eye Patients
NCT02161341 ·Status: COMPLETED
-
Evaluation of Lacrimal Punctal Changes by Anterior Segment Optical Coherence Tomography AS-OCT After Topical Combined Antibiotics and Steroids Treatment in Cases of Inflammatory Punctual Stenosis
NCT05028907 ·Status: COMPLETED ·Phase: PHASE4
-
The Beijing Adult Dry Eye Cohort Study
NCT06621446 ·Status: ACTIVE_NOT_RECRUITING
-
Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)
NCT04456556 ·Status: COMPLETED
-
Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability
NCT03063489 ·Status: COMPLETED ·Phase: PHASE1
-
Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion
NCT00735865 ·Status: COMPLETED ·Phase: NA
-
Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD)
NCT04314362 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment of Dry Eye Disease
NCT07298811 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Medication Compliance in the Paediatric Uveitis Population Reported by the Patients and Parents
NCT04148365 ·Status: COMPLETED
-
Evaluation of Safety and Tolerability of Investigational Ocular Lubricants
NCT05888519 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA
-
Clinical Efficacy of Amniotic Membrane Extract Eye Drops in Dry Eye Treatment
NCT05169931 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Installations
NCT03098953 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Antibiotics and Intravitreous Injections
NCT00410891 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of Eye Prophylaxis in the Newborn
NCT00000120 ·Status: COMPLETED ·Phase: PHASE3
-
Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs
NCT02819232 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.
NCT03698045 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
NCT02028312 ·Status: WITHDRAWN ·Phase: PHASE4
-
Topical Antibiotic Prophylaxis for Eyelids
NCT03199911 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Anterior Blepharitis With Microblepharoexfoliation Procedure
NCT04290455 ·Status: TERMINATED ·Phase: NA
-
Investigating Epstein-Barr Virus Associated Conjunctivitis
NCT06689397 ·Status: ENROLLING_BY_INVITATION
-
Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects
NCT01748578 ·Status: COMPLETED ·Phase: PHASE1
-
Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics
NCT00831961 ·Status: COMPLETED
-
Tofacitinib for Inflammatory Eye Disease
NCT03580343 ·Status: UNKNOWN ·Phase: PHASE2